Separate promising research from proven care.
posted on
By the Regenerative Evidence Guide Team Study Participants Receive Other Care Too: Reading the Co-Treatment Details Study participants receive other care too — not just the regenerative therapy a …
Continue Reading about Study Participants Receive Other Care Too: Reading the Co-Treatment Details →
posted on
By the Regenerative Evidence Guide Team The Short Answer There is no single "standard" follow-up length for regenerative medicine trials. Each study sets its own follow-up window separately for each …
Continue Reading about Regenerative Trial Follow-Up Periods Vary: What Long-Term Questions Remain →
posted on
By the Regenerative Evidence Guide Team An Exosome Offer Cites a Trial: What That Actually Tells You Say a clinic's website or a social media ad offers an exosome treatment for joint pain, and it …
Continue Reading about An Exosome Offer Cites a Trial: Matching the Product to the Registry →
posted on
By the Regenerative Evidence Guide Team Regenerative treatment costs mix several separate charges with a benefit that is often still unproven A regenerative treatment quote — for a stem cell, …
posted on
By the Regenerative Evidence Guide Team Where to Find Cell Therapy Safety Reports If you're trying to find out whether a stem cell, exosome, or other cell therapy product has caused serious harm to …
Continue Reading about Cell Therapy Safety Reports: Where to Look for Serious Events →
posted on
By the Regenerative Evidence Guide Team Say a clinic's flyer calls a stem cell injection "established" for knee pain. "Established" is a marketing word, not an FDA status. The FDA says regenerative …